NEPH · NASDAQ
Nephros (NEPH) Stock Price & Fundamentals
Nephros (NEPH) closed at $238.57 on Oct 9, 2026, up 1.74% from the previous close of $234.50.
Share price, past year
1Y +18.83%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $238.57 |
| Sep 30, 2026 | $223.13 |
| Aug 31, 2026 | $215.92 |
| Jul 31, 2026 | $220.51 |
| Jun 30, 2026 | $204.32 |
| May 29, 2026 | $213.18 |
| Apr 30, 2026 | $213.83 |
| Mar 31, 2026 | $207.89 |
| Feb 27, 2026 | $211.61 |
| Jan 30, 2026 | $201.69 |
| Dec 31, 2025 | $194.99 |
| Nov 28, 2025 | $191.02 |
| Oct 31, 2025 | $201.53 |
Key statistics
- Market cap
- $2.59B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $20.72M
- Net income (TTM)
- $1.74M
- Shares outstanding
- 10.9M
- Dividend yield
- —
- 52-week range
- $190.39 – $238.57
Nephros's market cap is $2.59B, based on a share price of $238.57 and 10.9M shares outstanding as of Jun 30, 2026.
Financials
Nephros reported revenue of $18.79M for fiscal 2025, up 32.67% from fiscal 2024.
Nephros earned net income of $1.19M in fiscal 2025, a net margin of 6.4%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $18.79M | +32.7% | $1.19M | 6.4% | $0.11 | — |
| FY2024ended Dec 31, 2024 | $14.16M | −0.5% | $74.00K | 0.5% | $0.01 | −$547.00K |
| FY2023ended Dec 31, 2023 | $14.24M | +42.7% | −$1.58M | −11.1% | −$0.15 | $752.00K |
| FY2022ended Dec 31, 2022 | $9.98M | −2.4% | — | — | −$0.73 | −$3.37M |
| FY2021ended Dec 31, 2021 | $10.22M | +19.3% | −$3.87M | −37.9% | — | −$1.45M |
| FY2020ended Dec 31, 2020 | $8.56M | −17.2% | −$4.53M | −52.9% | — | −$7.14M |
| FY2019ended Dec 31, 2019 | $10.33M | +81.7% | −$3.18M | −30.8% | — | −$2.29M |
| FY2018ended Dec 31, 2018 | $5.69M | +49.3% | −$3.40M | −59.8% | — | — |
| FY2017ended Dec 31, 2017 | $3.81M | +64.2% | −$809.00K | −21.2% | — | — |
| FY2016ended Dec 31, 2016 | $2.32M | — | −$3.03M | −130.7% | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $6.02M | $1.20M | $0.11 |
| Q1 FY2026ended Mar 31, 2026 | $5.21M | $140.00K | $0.01 |
| Q4 FY2025ended Dec 31, 2025 | $4.73M | $62.00K | — |
| Q3 FY2025ended Sep 30, 2025 | $4.76M | $337.00K | $0.03 |
| Q2 FY2025ended Jun 30, 2025 | $4.42M | $237.00K | $0.02 |
| Q1 FY2025ended Mar 31, 2025 | $4.88M | $558.00K | $0.05 |
| Q4 FY2024ended Dec 31, 2024 | $3.87M | $349.00K | — |
| Q3 FY2024ended Sep 30, 2024 | $3.52M | $183.00K | $0.02 |
Company profile
- Name
- Nephros, Inc.
- Ticker
- NEPH
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 380 Lackawanna Place, South Orange, NJ 07079
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001196298
Recent SEC filings
- Aug 10, 2026
- Aug 6, 2026
- Jun 15, 2026
- May 7, 2026
- May 7, 2026
- Apr 30, 2026
- Mar 27, 2026
- Mar 12, 2026
Frequently asked questions
What is Nephros's stock price?
Nephros (NEPH) closed at $238.57 on Oct 9, 2026, up 1.74% from the previous close of $234.50.
What is Nephros's market cap?
Nephros's market cap is $2.59B, based on a share price of $238.57 and 10.9M shares outstanding as of Jun 30, 2026.
How much revenue does Nephros make?
Nephros reported revenue of $18.79M for fiscal 2025, up 32.67% from fiscal 2024.
Does Nephros pay a dividend?
Nephros's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Nephros, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures